PIKfyve 抑制诱导抗瘤免疫因子性通过减轻 STING 贩运和溶酶体退化
Jie He1,2,3,4, Rui Huang1,2,4, Chunyan Zong1,2,4
1Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cancer immunology research
|May 22, 2025
概括
抑制PIKfyve通过促进IFN基因 (cGAS-STING) 循环GMP-AMP合成酶刺激通路来增强癌症免疫疗法. 这种方法改善了对抗PD-1疗法等现有治疗方法的反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 免疫检查点封锁在癌症治疗中表现有前途,但在反应率方面存在局限性.
- 激活IFN基因 (cGAS-STING) 循环GMP-AMP合成酶刺激器通路对于对瘤的先天免疫反应至关重要.
- 需要新的组合策略来提高癌症免疫疗法的疗效.
研究的目的:
- 为了确定cGAS-STING信号通路的新型调节器.
- 探索PIKfyve作为增强抗瘤免疫力的潜在治疗标.
- 评估PIKfyve抑制与现有的癌症疗法结合使用的疗效.
主要方法:
- 利用了连接地图数据库和激酶抑制剂图书馆屏幕.
- 评估了IFN刺激基因的功能读数.
- 通过使用遗传学和药理学方法,研究了PIKfyve在STING贩运和退化中的作用.
- 在黑色素瘤和B16F10瘤模型中评估治疗疗效.
主要成果:
- 确定了PIKfyve作为cGAS-STING信号的负调节器.
- 通过YM201636或基因切除抑制PIKfyve,上调IFN刺激基因和招募CD8+T淋巴细胞.
- 抑制PIKfyve使黑色素瘤对西斯普拉丁和抗PD-1联合治疗敏感,从而产生持久的反应.
- STING和CD8+T细胞枯竭减少了协同效应,证实了该机制.
结论:
- PIKfyve通过促进STING lysosomal降解来负面调节cGAS-STING信号传递.
- 抑制PIKfyve增强了抗瘤免疫反应,并提高了组合免疫疗法的疗效.
- 准PIKfyve是一个有希望的策略,可以增强STING信号和改善癌症治疗结果.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
12:08Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.4K
相关概念视频
Tumor Immunotherapy
677
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267
